SEIKAGAKU CORPORATION(4548) News

Seikagaku Announces Resubmission of Application to Obtain Approval in the U.S. for SI-6603

SEIKAGAKU, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 22%

[Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)

Seikagaku Announces Revision of Full-Year Consolidated Earnings Forecast, and Announcement of Full-Year Non-Consolidated Earnings Forecast

[Summary] Consolidated Financial Results (Japan GAAP) (Summary) for the First Six Months of Fiscal 2025 (Six-Month Period Ended September 30, 2025)

SEIKAGAKU, First Half Operating Profit Turns to Loss, Jul-Sep Operating Profit Turns to Loss

Seikagaku Announces an Application for Marketing Approval of SI-449, an Adhesion Barrier, as a Medical Device in Japan

Notice of Conclusion of a Definitive Agreement Regarding Co-development and Marketing Collaboration in Japan on Gel-One

[Summary] Consolidated Financial Results (Japan GAAP) (Summary) for the First Three Months of Fiscal 2025 (Three-Month Period Ended June 30, 2025)

SEIKAGAKU, Apr-Jun (1Q) Ordinary Profit Turns to Loss

Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation

[Summary]Consolidated Financial Results (Japan GAAP) (Summary) for the Fiscal 2024 (Year Ended March 31, 2025)

SEIKAGAKU, Operating Profit Unexpectedly Turn to Loss for Last Fiscal Year, The Current Fiscal Year's Operating Profit Turns to Loss

Seikagaku and Ono Reach a Basic Agreement Related to Co-development and Marketing Collaboration on Gel-One in Japan

SEIKAGAKU, The Current Fiscal Year Ordinary Profit Revised Downward by 48%

SEIKAGAKU, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 22%

SEIKAGAKU CORPORATION, July-September (2Q) Ordinary Profit Decreases by 54%